Ultan F. Power

Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection

Laurent Detalle, Thomas Stöhr, Concepción Palomo et al. · Antimicrobial Agents and Chemotherapy · 2015 · 289 citations · Full text

Skin Dendritic Cell Targeting <i>via</i> Microneedle Arrays Laden with Antigen-Encapsulated Poly-<scp>d</scp>,<scp>l</scp>-lactide-<i>co</i>-Glycolide Nanoparticles Induces Efficient Antitumor and Antiviral Immune Responses

Marija Zaric, Oksana Lyubomska, Olivier Touzelet et al. · ACS Nano · 2013 · 227 citations · Full text

Nanotherapeutics, Engineering, Dc Subsets +22

The viral protein corona directs viral pathogenesis and amyloid aggregation

Kariem Ezzat, Maria Pernemalm, Sandra Pålsson et al. · Nature Communications · 2019 · 213 citations · Full text

In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo

Rémi Villenave, Surendran Thavagnanam, Séverine Sarlang et al. · Proceedings of the National Academy of Sciences · 2012 · 204 citations · Full text

Asthma, Rsv Pathogenesis, Respiratory Diseases +13

Respiratory Syncytial Virus NS1 Protein Degrades STAT2 by Using the Elongin-Cullin E3 Ligase

Joanne Elliott, Oonagh T. Lynch, Yvonne Suessmuth et al. · Journal of Virology · 2007 · 176 citations · Full text